GlaxoSmithKline Intellectual Property Development Limited
发明人:
Wang, Rong,Hongtao, Lu
申请号：
AU2016203679
公开号：
AU2016203679A1
申请日:
2016.06.02
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016203679A120160623.pdf#####H: sxd lnterwoven NRPortbl DCC SXD 10242870_l.docx-1/06/2016 ABSTRACT This invention relates to novel therapeutic uses for compounds which are inverse agonsists of the H3 receptor. In particular this invention relates to therapeutic use of these compounds in the treatment of 5 Multiple Sclerosis.
